AMERICAS GOLD AND SILVER COR (USAS)

CA03062D1006 - Common Stock

0.2335  -0.01 (-3.95%)

After market: 0.2451 +0.01 (+4.97%)

Fundamental Rating

2

Overall USAS gets a fundamental rating of 2 out of 10. We evaluated USAS against 157 industry peers in the Metals & Mining industry. Both the profitability and financial health of USAS have multiple concerns. USAS is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

USAS had negative earnings in the past year.
In the past year USAS had a positive cash flow from operations.
USAS had negative earnings in each of the past 5 years.
In the past 5 years USAS reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -21.15%, USAS is doing worse than 79.62% of the companies in the same industry.
With a Return On Equity value of -82.28%, USAS is not doing good in the industry: 90.45% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -21.15%
ROE -82.28%
ROIC N/A
ROA(3y)-38.61%
ROA(5y)-27.76%
ROE(3y)-95.96%
ROE(5y)-65.71%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

USAS has a Gross Margin (19.01%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of USAS has declined.
USAS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-7.38%

0

2. Health

2.1 Basic Checks

USAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for USAS has been increased compared to 1 year ago.
Compared to 5 years ago, USAS has more shares outstanding
The debt/assets ratio for USAS is higher compared to a year ago.

2.2 Solvency

USAS has an Altman-Z score of -3.15. This is a bad value and indicates that USAS is not financially healthy and even has some risk of bankruptcy.
USAS has a Altman-Z score of -3.15. This is amonst the worse of the industry: USAS underperforms 92.99% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that USAS is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.46, USAS is not doing good in the industry: 73.25% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z -3.15
ROIC/WACCN/A
WACC9.08%

2.3 Liquidity

USAS has a Current Ratio of 0.40. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.40, USAS is not doing good in the industry: 95.54% of the companies in the same industry are doing better.
USAS has a Quick Ratio of 0.40. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.28, USAS is not doing good in the industry: 95.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.28

6

3. Growth

3.1 Past

USAS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.04%, which is quite impressive.
The Revenue has grown by 11.10% in the past year. This is quite good.
USAS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.55% yearly.
EPS 1Y (TTM)37.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)11.1%
Revenue growth 3Y47.55%
Revenue growth 5Y5.55%
Sales Q2Q%30.57%

3.2 Future

The Earnings Per Share is expected to grow by 23.28% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 23.10% on average over the next years. This is a very strong growth
EPS Next Y38.45%
EPS Next 2Y45.27%
EPS Next 3Y23.28%
EPS Next 5YN/A
Revenue Next Year21.26%
Revenue Next 2Y28.41%
Revenue Next 3Y23.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

USAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
USAS is valuated correctly with a Price/Forward Earnings ratio of 13.21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USAS is on the same level as its industry peers.
USAS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.22.
Industry RankSector Rank
PE N/A
Fwd PE 13.21

4.2 Price Multiples

USAS's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 40.21

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
USAS's earnings are expected to grow with 23.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.27%
EPS Next 3Y23.28%

0

5. Dividend

5.1 Amount

No dividends for USAS!.
Industry RankSector Rank
Dividend Yield N/A

AMERICAS GOLD AND SILVER COR

NYSEARCA:USAS (9/6/2024, 8:04:00 PM)

After market: 0.2451 +0.01 (+4.97%)

0.2335

-0.01 (-3.95%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap61.58M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.21
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.15%
ROE -82.28%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.01%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.4
Quick Ratio 0.28
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)37.04%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y38.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.1%
Revenue growth 3Y47.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y